Albany Molecular Research, Inc. (AMRI)
Delisted
31 Aug 2017
NASDAQ (NGS) NASDAQ (NGS) Primary $
21. 74
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
582,989 Volume
- Eps
$ 21.74
Previous Close Investors:
Day Range
21.73 21.76
Year Range
13.01 22.17
Want to track AMRI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.
AMRI Chart
Albany Molecular Research, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| GN Gina Nelson Next Century Growth Investors LLC | 99,130 | $6.11M | $6.11M | - | - |
Albany Molecular Research, Inc. (AMRI) FAQ
What does "Delisted" mean?
Albany Molecular Research, Inc. has been removed from the exchange and is no longer publicly traded.
What was the last recorded dividend?
No dividend payments were recorded prior to delisting.
How long did the company pay dividends?
The company did not have a dividend payment history.
Were there any stock splits?
The last recorded stock split occurred on Aug 25, 2000 with a ratio of 2:1.
What was the last known trading price?
The stock last traded at $21.74 on Aug 31, 2017 before being delisted.
